Open access
1,227
Views
0
CrossRef citations to date
0
Altmetric
Original Articles
Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis
Nicolay Jonassen Harbina Antibiotic Center for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, NorwayCorrespondence[email protected]
View further author information
, View further author information
Karin Rystedtb Research, Education, Development and Innovation, Primary Health Care, Region Västra Götaland, Sweden;c General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;d Centre for Antibiotic Resistance Research (CARe) at University of Gothenburg, Gothenburg, Sweden;e Region Västra Götaland, Närhälsan Stenstorp vårdcentral, Stenstorp, SwedenView further author information
, Morten Lindbaeka Antibiotic Center for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, NorwayView further author information
, Ruta Radzevicienef Mano Seimos gydytojas, Klaipeda, LithuaniaView further author information
, Johan Westing Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, SwedenView further author information
, Ronny Gunnarssonb Research, Education, Development and Innovation, Primary Health Care, Region Västra Götaland, Sweden;c General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;d Centre for Antibiotic Resistance Research (CARe) at University of Gothenburg, Gothenburg, SwedenView further author information
, Christopher C. Butlerh Department of Primary Care Health Services, University of Oxford, Radcliffe Observatory Quarter, Oxford, UKView further author information
, Alike W. van der Veldeni Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the NetherlandsView further author information
, Theo J. Verheiji Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the NetherlandsView further author information
& Pär-Daniel Sundvallb Research, Education, Development and Innovation, Primary Health Care, Region Västra Götaland, Sweden;c General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;d Centre for Antibiotic Resistance Research (CARe) at University of Gothenburg, Gothenburg, SwedenView further author information
show all
Pages 527-532
|
Received 26 Mar 2021, Accepted 11 Aug 2021, Published online: 01 Dec 2021
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.